Streetbeat News

Revenues

ADNT

Adient (NYSE:ADNT) reported Q3 2024 sales of $3.716 billion, missing the analyst consensus estimate of $3.826 billion by 2.87%. This represents an 8.36% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:53 am

MPLX

MPLX (NYSE:MPLX) reported Q2 2024 earnings per share (EPS) of $1.15, surpassing the analyst consensus estimate of $0.99 by 16.16%. The company's quarterly sales were $3.052 billion, exceeding the estimate of $2.958 billion by 3.19%. Both EPS and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:53 am

MPLX

MPLX (NYSE:MPLX) reported Q2 2024 earnings of $1.15 per share, beating the analyst estimate of $0.99. Sales were $3.052 billion, surpassing the $2.958 billion estimate. Both earnings and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:53 am

ENR

Energizer Holdings (NYSE:ENR) reported Q3 earnings of $0.79 per share, beating the analyst estimate of $0.67 by 17.91%. However, sales of $701.40 million missed the estimate of $706.23 million by 0.68%. Earnings increased by 46.3% year-over-year, while sales saw a slight increase of 0.29%.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:52 am

ANIP

ANI Pharmaceuticals reported Q2 2024 adjusted EPS of $1.02, beating the estimate of $0.95. Sales for the quarter were $138.040 million, surpassing the expected $129.054 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:51 am

CEG

Constellation Energy (NASDAQ:CEG) reported Q2 2024 adjusted EPS of $1.68, missing the analyst estimate of $1.72. Sales were $5.475 billion, also missing the estimate of $5.550 billion. Sales increased by 0.53% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:49 am

SOPH

Sophia Genetics (NASDAQ:SOPH) reported Q2 2024 GAAP EPS of $(0.23), beating the estimate of $(0.28). However, sales of $15.808M missed the $17.400M estimate, though they increased by 5.01% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:48 am

KVUE

Kenvue has reaffirmed its outlook for 2024, projecting net sales growth of 1.0%-3.0% (2.0%-4.0% organic growth) and adjusted EPS of $1.10-$1.20, which aligns with the consensus estimate of $1.14.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:47 am

BLD

TopBuild (NYSE:BLD) reported Q2 earnings of $5.42 per share, missing the analyst estimate of $5.68. Sales were $1.37 billion, also below the $1.40 billion estimate. Despite the misses, earnings and sales increased year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:47 am

OLPX

Olaplex Holdings reported Q2 2024 adjusted EPS of $0.03, which was in line with expectations. The company also reported sales of $103.90 million, beating the estimate of $103.65 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 10:47 am